This work is licensed under a Creative Commons Attribution 4.0 International License.
General Information
DRACP ID DRACP04084
Peptide Name
Sequence KWWKLLRKKR
Sequence Length 10
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C70H116N22O11
Absent amino acids ACDEFGHIMNPQSTVY
Common amino acids K
Mass 160254
Pl 12.56
Basic residues 6
Acidic residues 0
Hydrophobic residues 4
Net charge 6
Boman Index -3754
Hydrophobicity -188
Aliphatic Index 78
Half Life
Mammalian: 1 hour
Yeast: 30 min
E.coli: >10 hour
Extinction Coefficient cystines 11000
Absorbance 280nm 1222.22
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 33074344
Title Novel formulation of antimicrobial peptides enhances antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA)
Doi Not available
Year 2020
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 16921
This work is licensed under a Creative Commons Attribution 4.0 International License.